Morgan Cheatham

Morgan Cheatham is an accomplished professional with extensive experience in healthcare, life sciences, and computational applications. Currently serving as Vice President at Bessemer Venture Partners since 2017, Morgan is also a Co-Founder of Decoding Bio and has recently joined the Coalition for Health AI as a Board Member. Additionally, Morgan holds positions on the NEJM AI Editorial Team and as a Limited Partner at Silver Beech Capital Management and First Close Partners. Morgan's previous roles include serving as a Board Director and Interim Chief Executive Officer at FOLX Health, and holding analyst positions at Goldman Sachs and Kyruus. Morgan's academic credentials include a Doctor of Medicine from The Warren Alpert Medical School of Brown University and a Bachelor of Science in Computational Decision Sciences from Brown University. Recognized as part of Forbes' 30 Under 30 in Venture Capital, Morgan continues to contribute significantly to the intersection of technology and healthcare.